Profs. Daron Acemoglu and David Autor speak with New York Times correspondent Thomas B. Edsall about the forces driving working-class voters towards the Republican party. “Elites are making choices that are not good news for non-college workers,” said Acemoglu. “In fact, they are bad news for most workers.”
QuEra, co-founded by faculty from MIT and Harvard, is a quantum computing startup that uses “neutral atoms in a vacuum chamber and use lasers to cool and control them,” reports Jane Lanhee Lee for Reuters. The startup has announced its “computer is now accessible to the public through Amazon.com cloud’s quantum compute service Braket,” writes Lee.
Vaxxes, a Cambridge startup based on research conducted at MIT and Tufts University, is working toward “the creation of a vaccine that’s easy to use, doesn’t require refrigeration, and releases slowly in the skin for a stronger immune response,” reports Ryan Cross for The Boston Globe.
Wasalu Jaco (professionally known as Lupe Fiasco), an MLK Visiting Scholar, speaks with MLK Visiting Prof. C. Brandon Ogbunu about his appointment at MIT, views on the music industry and advice for creatives. “From a research standpoint, I was like, ‘I need new things to talk about.’ Then you realize, ‘Oh, rapping isn’t just songs, it isn’t just creating bars. It’s the way we arrange ideas in a novel way,’” says Jaco. “And then I ask: Is there something deeper to that, and what’s the best space to explore that? It’s the academic space, the laboratory space.”
Principal research scientist Leo Anthony Celi speaks with Associated Press reporter Maddie Burakoff about how pulse oximeters can provide inaccurate readings in patients of color. Celi highlights how oxygen levels can also be measured by drawing blood out of an artery in the wrist, the “gold standard” for accuracy, but a method that is a a bit trickier and more painful.
Postdoctoral fellow Suhas Eswarappa Prameela speaks with Science Careers about how to develop and maintain successful relationships with advisors, mentors, and supervisors. “Faculty members are inundated with multiple administrative, teaching, and service activities, so being proactive, articulating your needs, and clearly communicating hurdles in the lab is key,” notes Prameela.
Biobot, a sewage data company co-founded by Mariana Matus PhD ’18 and Newsha Ghaeli PhD ’17, uses wastewater analysis to track the spread of Covid-19, reports Faye Flam for Bloomberg. “This kind of data gives Covid-cautious people the information they need to reduce their risk,” writes Flam.
Writing for The Boston Globe, Prof. Linda Griffith underscores the pressing need to invest in studying women’s health and menstruation science. “These were the attitudes society had about breast cancer decades ago; we didn’t talk about it. But then we finally focused on the science, and overcame the squeamishness about mentioning ‘breasts’ by creating a technical language that could be spoken without hesitation by anyone,” writes Griffith. “We need a similar scientific push for menstruation science, and a comfort level with the language that goes with it. It’s time.”
Jamie Karraker BS ’12 MS ’13 co-founded Alto Pharmacy – a full-service, online pharmacy that aims to create a transparent, straightforward and user-friendly experience, reports Erika Fry for Fortune. “All patients need to do after seeing their doctor is interface with the app (or via text) and pick up the prescription from their front door,” writes Fry.
MIT startup Quaise Energy is developing an energy-based drill to make geothermal power more accessible, reports Catherine Clifford for CNBC. “The solution to drilling is to replace the mechanical grinding process with a pure energy-matter interaction,” says research scientist Paul Woskov. “Sufficient energy intensity will always melt-vaporize rock without need for physical tools.”
Landmark Bio, a cell and gene therapy manufacturing company co-founded by MIT and a number of other institutions, is focused on accelerating access to innovative therapies for patients, reports Rowan Walrath for Boston Business Journal. "Landmark's new facility includes laboratory space for research and early-stage drug development, as well as analytics tools,” writes Walrath.
MIT and a number of other local institutions have launched Landmark Bio, a cell and gene therapy manufacturing firm aimed at helping small startups develop experimental therapies that are reliable, consistent, and large enough to be used in clinical trials, reports Ryan Cross for The Boston Globe.
Prof. Alan Lightman is the host of an upcoming docuseries, Searching: Our Quest for Meaning in the Age of Science, which will premiere on PBS in January. “Lightman’s areas of inquiry are as vast as the universe and as tiny as the smallest particle of matter,” writes Matthew Carey for Deadline. He “brings to his explorations the rigor of a scientist and the artistic sensibility of a poet.”
Forbes contributor Anuradha Varanasi spotlights a new study co-authored by MIT researchers that finds that in China, “masks might function as a ‘moral symbol’ and decrease the likelihood of an individual engaging in any form of deviant behavior.”
Prof. Peter Shor has been named one of the winners of the 2023 Breakthrough Prize in Fundamental Physics, reports Nature. “Shor’s most renowned contribution is the development of quantum algorithms for prime number factorization,” writes Nature.